 Analysts expect Heron Therapeutics Inc NASDAQ:HRTX to report earnings of 0.60 per share for the current fiscal quarter, Zacks reports. Four analysts have made estimates for Heron Therapeutics earnings, with the highest EPS estimate coming in at 0.56 and the lowest estimate coming in at 0.67. Heron Therapeutics posted earnings per share of 0.63 in ... 